SAIUmet-G-250
Description_Effects
SAIUmet-G-250 is a combination antidiabetic medication that contains Glimepiride and Metformin, two widely used drugs that help manage type 2 diabetes mellitus. This combination is designed to provide better blood sugar control in patients whose diabetes is not adequately controlled by diet, exercise, or monotherapy alone. Glimepiride is a sulfonylurea, which works by stimulating the pancreas to release more insulin. It helps lower blood sugar levels in the body, especially after meals. On the other hand, Metformin is a biguanide that works primarily by reducing glucose production in the liver, decreasing intestinal glucose absorption, and improving insulin sensitivity in muscle cells. Together, these actions help maintain a more stable and controlled blood glucose level throughout the day. SAIUmet-G-250 is usually prescribed alongside lifestyle changes such as a healthy diet, regular physical activity, and weight management. This combination not only improves glycemic control but may also reduce the risk of diabetes-related complications like nerve damage, kidney problems, and cardiovascular issues. Patients taking SAIUmet-G-250 should be monitored regularly for blood sugar levels, kidney function, and any signs of hypoglycemia. It is important to follow the prescribed dosage and schedule as advised by a healthcare provider.
